Clinical Trials Directory

Trials / Completed

CompletedNCT00931268

Morphological and Functional Evaluation of Buttock Lipoatrophy Treatment With Macrolane

Morphological and Functional Evaluation of Buttock Lipoatrophy Treatment With Stabilized Hyaluronic Acid of Non-animal Origin (Macrolane); a Baseline-controlled Single-centre Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The study is being undertaken to establish the effectiveness and safety of Macrolane volume restoration factor 30 (VRF30) when used for treatment of HIV-infected subjects with buttocks lipoatrophy.

Conditions

Interventions

TypeNameDescription
DEVICEMacrolane VRF 30One administration

Timeline

Start date
2009-08-01
Primary completion
2011-09-01
Completion
2012-05-01
First posted
2009-07-02
Last updated
2022-09-28
Results posted
2013-12-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00931268. Inclusion in this directory is not an endorsement.

Morphological and Functional Evaluation of Buttock Lipoatrophy Treatment With Macrolane (NCT00931268) · Clinical Trials Directory